Accuray Elevated to NASDAQ Global Select Market
SUNNYVALE, Calif., Jan. 3, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it has been named to the NASDAQ Global Select Market, the premier listing tier for NASDAQ companies. The NASDAQ Global Select Market is designated for public companies that meet the highest listing standards in the world, with measures including market value, liquidity and earnings.
"We are honored to be added to the NASDAQ Global Select Market, joining some of the most respected companies in the world who also uphold NASDAQ's rigorous qualification standards," said Euan Thomson, Ph.D., president and CEO of Accuray. "In the last year, we have celebrated several milestones including the FDA clearance of the CyberKnife System's Lung Optimized Treatment, the launch of the CyberKnife VSI System and our 200th worldwide install. Inclusion in this listing further emphasizes our overall growth as a company, as well as our solid financial performance and long-term growth potential."
Accuray was previously listed on the NASDAQ Global Market. Accuray's shares will be transferred to the Global Select Market at the opening of business today, January 3, 2011, and will continue to be traded under the ticker ARAY.
About the CyberKnife® Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invas